Slide 1: Presentation for investors, analysts and media
Presentation for investors, analysts and media Basel, 14 August, 2024
Slide 2: Forward-looking statements
This presentation contains forward-looking statements that reflect the current views of management, and which are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ materially from those expr
Slide 3: Agenda
Highlights Guillaume Daniellot Financials Yang Xu Recent achievements & strategy Guillaume Daniellot Outlook 2024 Guillaume Daniellot Q&A Guillaume Daniellot, Yang Xu 3
Slide 4: Highlights
ext = @ E Paeiea con Re es fed oo fotado) Ola of BiB = fig HIGHLIGHTS Guillaume Daniellot,
Slide 5: Highlights
Revenue in CHF Organic revenue growth1 Core profitability 1.3 bn 16.1% 27.8% CHF 655 m revenue in the second quarter 14.8 % organic growth1 in Q2, 28.9% at constant FX2, IFRS EBIT margin 26.4% currency headwinds (12.4% in CHF) strong currency headwinds Consumer presence Implantology Updated outlook
Slide 6: Regional revenue growth
NAM EMEA Q2 5.3% Q2 12.4% Q2 23 7.0% 40 %* Q2 23 9.3% 28 %* 23% * GROUP 9%* LATAM APAC Q2 14.9% Q2 33.8% Q2 23 20.1% Q2 23 23.1% 6 * % of Group total revenue; continuing operations
Slide 7: Yang Xu, CFO
Yang Xu, CFO 7
Slide 8: Change in organic growth
Regional % +12.4% +14.8% share of organic growth Organic 8 655 39 9% LATAM 11% NAM 9 29 34% EMEA 583 7 570 -20 Change in organic growth 46% APAC +12.4%1 +5.3% +33.8% +14.9% Revenue FX effect M&A effect Adjusted EMEA NAM APAC LATAM Revenue Q2 2024 Q2 2023 revenue base Q2 2024 8 1 including discontinu
Slide 9: IFRS gross profit margin
75.3 0.0 -180 bps 74.3 -1.0 0.1 72.5 72.1 -1.9 -0.3 IFRS gross Non-core FX effect Core gross Portfolio Productivity Core gross Non-core IFRS gross profit margin items profit margin mix effect effect profit margin items profit margin HY1 2023 HY1 2023 HY1 2024 HY1 2024 @FX 2023 @FX 2024 @FX 2024 @FX
Slide 10: IFRS EBIT margin
-120 bps +70 bps 1.7 2.6 0.2 27.8 27.3 27.1 26.4 -1.9 -1.4 -1.8 -0.3 IFRS EBIT Non-core FX effect Core EBIT Gross profit Distribution Administration Other Core EBIT Non-core IFRS EBIT Margin items margin change expense expense income margin items margin HY1 2023 HY1 2023 HY1 2024 HY1 2024 @FX 2023 @
Slide 11: Free Cashflow
Free Cashflow CHF 145m (11.4% of Net Revenue) in H1 2024 vs. CHF 143m (12.5% of Net Revenue) in H1 2023 -18.7% 203 -117 -156 410 -7 334 Cash Net Cash Net Cash Net Cash Less cash from Cash 1 Jan Operating Investing Financing & Other discontinued operations 30 Jun 2024 2024 11
Slide 12: Income statement HY1 2024 core
In CHF million, rounded HY1 2024 % of revenue Margin change Change in % Comments Revenue 1’273 17.6% COGS -350 27.5% 25.8% GROSS PROFIT 923 72.5% -180 bps FX headwind -100 bps Operating expenses -575 45.1% 11.9% EBIT 354 27.8% +70 bps FX headwind -190 bps Financial result -6 0.5% -70.4% Associates -
Slide 13: Continuing operations growth and margin
Organic revenue Core EBIT Core EBIT growth margin margin (2023 FX1)) Continuing +16.1% 27.8% 28.9% operations Group incl. +12.9% 24.9% 26.0% disc. ops. 13 1 at 2023 full-year average FX rates
Slide 14: Tooth replacement, tooth alignment, digital solutions
Tooth replacement Tooth alignment Digital solutions and restoration 14
Slide 15: Recent achievements & strategy
RECENT ACHIEVEMENTS & STRATEGY Guillaume Daniellot, CEO
Slide 16: Innovations shown at ITI
Innovations shown at ITI new iExcel Straumann Falcon Sirios 16
Slide 17: CBCT, IOS, Clear Aligner portfolio
CBCT IOS Clear Aligner Smile in a Box Straumann UN!Q 17
Slide 18: Straumann AXS
umann AX End-to-end digital user ra S St experience in AXS Enhanced portfolio Service excellence Planning Design Manufacturing 18
Slide 19: Customer testimonial on unified prosthetic platform
“A unified prosthetic platform with a single abutment connection is a game changer. It makes implant dentistry safer and more efficient.” Dr. German Gallucci, Boston, MA 19
Slide 20: Technology, Service, Go-to-market
Technology Service Go-to-market 20
Slide 21: Acquisition of Spanish aligner provider
o Based in Spain, Barcelona o Leading provider for direct-to-consumer o Wide product range - Clear aligners, professional aligners in Europe whitening and veneers o Established marketing teams o Tech Stack - Advanced technology & AI-optimized o Partner network of dental professionals in app Europe o
Slide 22: Management changes
Sara Dalmasso joining Straumann Arnoud Middel Thomas Friese new member EMB Matthias Schupp leaving Straumann Group Head of DSO Chief People Officer Chief Technology & Information Officer CEO of Medartis Following Alastair Robertson Former Chief Technology Officer Former Head of LATAM 22
Slide 23: Straumann Group outlook
straumanng/oup
Slide 24: Growth ambition 2030 confirmed
Market environment and assumption Revenue and profitability • Uncertain economic environment remains • Organic revenue growth in the low double-digit percentage range • Group believes global patient flow should remain stable • Profitability in the 27-28% range at constant 2023 currency rates1 • Outg
Slide 25: Thank you
U NK YO JHA be ee,
Slide 26: Upcoming events
2024 Event Location 15-16 Aug Jefferies Roadshow London 4-5 Sep Goldman Sachs European Med-tech Conference London 10-11 Sep Kepler Cheuvreux Autumn Conference Paris 18-19 Sep Bank of America Global Healthcare Conference London 29 Oct Straumann Q3 results 26
Slide 27: Revenue breakdown and exchange rates
Revenue breakdown H1 2024 Exchange rates development 2023 – Jun 2024 110 . Other EUR 20.0% 26.0% 100 CHF BRL 1.5% 6.2% 90 CNY 14.6% 80 12/2022 03/2023 06/2023 09/2023 12/2023 03/2024 06/2024 USD/CAD/AUD 31.7% USDCHF EURCHF CNYCHF BRLCHF Total cost breakdown H1 2024 FX sensitivity Other Average excha
Slide 28: HY1 2024 IFRS income statement
In CHF million, rounded HY1 2024 % of revenue Margin change Change in % Comments Revenue 1’273 17.6% COGS -355 27.9% 25.8% GROSS PROFIT 918 72.1% -210 bps FX headwind -100 bps Operating expenses -589 46.2% 10.6% EBIT 336 26.4% +100 bps FX headwind -190 bps Financial result -5 0.4% -80.6% Associates
Slide 29: H1 2024 IFRS to core reconciliation
H1, 2024 (in CHF 1 000) IFRS M&A Restructuring Legal cases CORE Revenue 1 273 232 0 1 273 232 Cost of goods sold (354 833) 2 877 1 492 (350 464) Gross profit 918 399 2 877 1 492 0 922 768 Other income 6 379 6 379 Distribution expense (241 273) 3 199 76 (237 997) Administrative expense (347 446) 5 12
Slide 30: Thank you
NK YOU JHA ba i